A Label, a Wrong Diagnosis, and an Irreversible Surgery
Cassandra Barksdale walked into Kaiser Permanente Southwood Medical Center in Jonesboro, Georgia, in early 2025 seeking answers for heavy bleeding and fibroids — noncancerous growths in and around the uterus. She left on a path toward a surgery she never needed.
On March 10, 2025, Barksdale underwent a biopsy. Seven days later, on March 17, she received results indicating an aggressive form of endometrial uterine cancer. According to a lawsuit filed Tuesday, the tissue sample bearing that diagnosis belonged to a different patient entirely. A labeling error had attached a stranger's cancer to Barksdale's name.
On May 15, 2025, Barksdale — then 43 years old — underwent a full hysterectomy and was told to expect instructions about chemotherapy. She spent months believing she was dying. 'I even started making funeral plans with them to let them know, you know, if I don't make it out, this is what I want done,' Barksdale said.
It was not until September 2025 that a DNA analysis confirmed the cancerous tissue belonged to someone else. By then, the surgery was long done and the damage — physical and psychological — was permanent.
The Lawsuit and Kaiser's Response
Barksdale and her attorneys filed suit against Kaiser Permanente on Tuesday, August 5, 2026. Her attorney, Shannan Young, framed the case in direct terms: 'She came into Kaiser Permanente looking for answers, and she left with a diagnosis that did not belong to her. And every step that was taken after that was based off of misinformation.'
Kaiser Permanente issued a statement acknowledging the incident. 'Ms. Barksdale should not have experienced this,' the statement read. 'We have highly trained staff and very thorough processes in place to prevent errors like this from taking place. After this occurred last year, we took immediate steps to ensure it could not happen again. We realize the impact of this incident and are committed to working with Ms. Barksdale and her counsel to resolve this in the most fair and accountable way we can.'
The statement did not specify what corrective steps were taken.
Because of privacy laws, information about the other patient — including whether her cancer treatment was delayed as a result of the mixup — is not publicly available.
A Systemic Problem Without a Clear Count
How frequently pathology samples are mislabeled is not precisely known. An Ohio woman filed a similar lawsuit alleging a 2019 biopsy error led to a misdiagnosis of lung cancer and unnecessary surgery. A 2011 research paper on prostate cancer identified three cases of biopsy sample misidentification over two years. Labs have adopted barcode systems and point-of-care testing to reduce such errors, but the practice is uneven.
Young put the accountability question plainly: 'There's no amount of money that's going to return back to her, her healthy organs, or erase the experiences and the pain that she's had. But our justice system recognizes that when somebody's negligence harms another person, accountability requires more than 'I'm sorry.''
CEO Times Editorial Read
Kaiser Permanente's statement — 'highly trained staff and very thorough processes' — is the language of institutional self-assurance, not of demonstrated accountability. A woman lost a healthy organ. Her children prepared for her death. The system that caused the harm is also the system that investigated it internally and decided what steps to take next.
Free enterprise depends on liability as a disciplining force. When institutions face real legal and financial consequences for negligence, they invest in better systems. That is the logic behind Barksdale's lawsuit — and it is sound. The market for healthcare accountability runs through the courthouse, and this case will test whether that mechanism still works.
